Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $129.26 USD
Change Today +4.63 / 3.71%
Volume 1.1M
BMRN On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jean-Jacques Bienaime MBA

Chairman and Chief Executive Officer,BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 34 board members in 5 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Jean-Jacques Bienaime, MBA has been the Chief Executive Officer of Biomarin Pharmaceutical Inc. since May 2005. Mr. Bienaime served as the Chief Executive Officer and President of Danisco US Inc. (formerly, Genencor) from November 2002 to April 2005. He has over 25 years of experience in the biotechnology and pharmaceutical industries. Before Genencor, Mr. Bienaime served as the President since June 1998, Chief Executive Officer since February 1999 and Chief Operating ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Chairman and Chief Executive Officer
Director and Member of Compensation Committee


University of Pennsylvania - The Wharton School
ESCP Europe

Other Affiliations*

Annual Compensation*

Total Annual Compensation$916,030

Stock Options*

Restricted Stock Awards$3,211,790
All Other Compensation$38,177
Exercised Options46,000
Exercised Options Value$2,807,712
Exercisable Options2,000,170
Exercisable Options Value$128,013,064
Unexercisable Options379,094
Unexercisable Options Value$12,060,906
Total Value of Options$142,881,682
Total Number of Options2,425,264

Total Compensation*

Total Annual Cash Compensation$1,819,082
Total Short Term Compensation$916,030
Other Long Term Compensation$3,249,967
Total Calculated Compensation$10,898,392
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $129.26 USD +4.63


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Craig A. Wheeler Chief Executive Officer, President and Executive Director
Momenta Pharmaceuticals Inc.
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at